Zoghbi Huda Y
SEC Form 4 insider trading activity
Zoghbi Huda Y has filed 3 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Zoghbi Huda Y is listed as Director at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, Zoghbi Huda Y reported no open-market purchases and 2 open-market sales totaling $1.9M in REGN. The largest disclosed transaction in the window is a sale of 1,638 REGN shares on Feb 19, 2026, worth $1.3M.
Companies traded
Other insiders at REGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Zoghbi Huda Y made?
Zoghbi Huda Y has filed 3 SEC Form 4 filings (15 transaction rows) across 1 company since 2026.
Which companies does Zoghbi Huda Y trade?
Zoghbi Huda Y has filed SEC Form 4 disclosures for 1 company, including REGN.
When was Zoghbi Huda Y's most recent SEC Form 4 filing?
Zoghbi Huda Y's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Zoghbi Huda Y's total buy and sell value in the current window?
Inside the rolling retention window, Zoghbi Huda Y bought $0 and sold $1.9M based on SEC Form 4 filings.
What was Zoghbi Huda Y's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,638 REGN shares on 2026-02-19, worth $1.3M, per SEC Form 4 filings.